Antitrypanosomal isoflavan quinones from Abrus precatorius

Area of Science:

• Natural Product Chemistry
• Medicinal Chemistry
• Parasitology

Background:

• Human African trypanosomiasis is a fatal neglected tropical disease prevalent in sub-Saharan Africa.
• There is an urgent need for novel therapeutic agents to combat this disease.
• Abrus precatorius is a potential source of natural products with antitrypanosomal activity.

Purpose of the Study:

• To isolate and characterize new abruquinones from Abrus precatorius.
• To evaluate the in vitro antitrypanosomal activity and selectivity of isolated compounds.
• To determine the absolute configuration of newly identified compounds.

Main Methods:

• Phytochemical investigation involving extraction and isolation of compounds from Abrus precatorius.
• Structural elucidation using HR-ESI-MS and comprehensive 1D and 2D NMR spectroscopy.
• Determination of absolute configuration via electronic circular dichroism (ECD) spectroscopy.

Main Results:

• Three new abruquinones (J, K, L) and two known abruquinones (A, D) were isolated.
• Compounds K, A, and D exhibited potent in vitro activity against Trypanosoma brucei rhodesiense with IC50 values as low as 0.01 μM.
• High selectivity indices (SIs) were observed, with values up to 1379, indicating a favorable safety profile.

Conclusions:

• Abrus precatorius is a valuable source of potent antitrypanosomal compounds.
• Abruquinones K, A, and D demonstrate significant potential for the development of new treatments for Human African trypanosomiasis.
• Further in vivo studies are warranted to evaluate the efficacy of these compounds.